Human medicines

EMA is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU. In 2019, EMA received a record number of requests for scientific advice. The numbers of applications for marketing authorisation were up again and EMA recommended 66 new medicines for marketing authorisation. EMA continued to closely monitor the safety of medicines on the market and take action when needed. The product information for 405 centrally authorised medicines was updated on the basis of new safety data. Here are some key figures on the authorisation and safety monitoring of medicines for human use in 2019. For more detailed information, download the full annual report 2019 (PDF version).